Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Leon Bradlow

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
In Vivo (Athens, Greece)|August 21, 2008
Review. Indole-3-carbinol as a chemoprotective agent in breast and prostate cancerH Leon Bradlow
Hormone Molecular Biology and Clinical Investigation|November 6, 2014
Obesity and the gut microbiome: pathophysiological aspectsH Leon Bradlow
Annals of the New York Academy of Sciences|July 4, 2002
Diet and breast cancerH Leon Bradlow, Daniel W Sepkovic
Annals of the New York Academy of Sciences|January 15, 2005
Steroids as procarcinogenic agentsH Leon Bradlow, Daniel W Sepkovic
Annals of the New York Academy of Sciences|March 3, 2009
Estrogen hydroxylation--the good and the badDaniel W Sepkovic, H Leon Bradlow
In Vivo (Athens, Greece)|June 29, 2011
Adipocyte-derived factor as a modulator of oxidative estrogen metabolism: implications for obesity and estrogen-dependent breast cancerH Leon Bradlow, Daniel W Sepkovic, Nitin Telang, et al.
The Journal of Nutrition|November 22, 2008
3,3'-Diindolylmethane and genistein decrease the adverse effects of estrogen in LNCaP and PC-3 prostate cancer cellsSunyata Smith, Daniel Sepkovic, H Leon Bradlow, et al.
Annals of the New York Academy of Sciences|March 3, 2009
Clues to understanding the oxidation of estradiol in humans: effects of acute infectious hepatitis, autoimmune hepatitis, and chronic liver diseaseRobert G Lahita, Robert A Schaefer, H Leon Bradlow, et al.
Nutrition and Cancer|January 1, 2014
Comparative efficacy of extracts from Lycium barbarum bark and fruit on estrogen receptor positive human mammary carcinoma MCF-7 cellsNitin Telang, Gou Li, Daniel Sepkovic, et al.
Familial Cancer|January 24, 2015
The effect of oral 3,3'-diindolylmethane supplementation on the 2:16α-OHE ratio in BRCA1 mutation carriersDina Nikitina, Marcia Llacuachaqui, Daniel Sepkovic, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
In Vivo (Athens, Greece)|August 21, 2008
Review. Indole-3-carbinol as a chemoprotective agent in breast and prostate cancerH Leon Bradlow
Hormone Molecular Biology and Clinical Investigation|November 6, 2014
Obesity and the gut microbiome: pathophysiological aspectsH Leon Bradlow
Annals of the New York Academy of Sciences|July 4, 2002
Diet and breast cancerH Leon Bradlow, Daniel W Sepkovic
Annals of the New York Academy of Sciences|January 15, 2005
Steroids as procarcinogenic agentsH Leon Bradlow, Daniel W Sepkovic
Annals of the New York Academy of Sciences|March 3, 2009
Estrogen hydroxylation--the good and the badDaniel W Sepkovic, H Leon Bradlow
In Vivo (Athens, Greece)|June 29, 2011
Adipocyte-derived factor as a modulator of oxidative estrogen metabolism: implications for obesity and estrogen-dependent breast cancerH Leon Bradlow, Daniel W Sepkovic, Nitin Telang, et al.
The Journal of Nutrition|November 22, 2008
3,3'-Diindolylmethane and genistein decrease the adverse effects of estrogen in LNCaP and PC-3 prostate cancer cellsSunyata Smith, Daniel Sepkovic, H Leon Bradlow, et al.
Annals of the New York Academy of Sciences|March 3, 2009
Clues to understanding the oxidation of estradiol in humans: effects of acute infectious hepatitis, autoimmune hepatitis, and chronic liver diseaseRobert G Lahita, Robert A Schaefer, H Leon Bradlow, et al.
Nutrition and Cancer|January 1, 2014
Comparative efficacy of extracts from Lycium barbarum bark and fruit on estrogen receptor positive human mammary carcinoma MCF-7 cellsNitin Telang, Gou Li, Daniel Sepkovic, et al.
Familial Cancer|January 24, 2015
The effect of oral 3,3'-diindolylmethane supplementation on the 2:16α-OHE ratio in BRCA1 mutation carriersDina Nikitina, Marcia Llacuachaqui, Daniel Sepkovic, et al.
Pageof 4